(-)-2-Oxa-4-aminobicylco[3.1.0]hexane-4,6-dicarboxylic acid (LY379268) and 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine (MTEP) similarly attenuate stress-induced reinstatement of cocaine seeking

Addiction Biology

Volumn 17, Issue 3, 2012, Pages 557-564

  Martin Fardon, Rémi ^a   Weiss, Friedbert ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Addiction; cocaine seeking behavior; LY379268; MTEP; self administration; stress

Indexed keywords

3 [(2 METHYL 4 THIAZOLYL)ETHYNYL]PYRIDINE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; COCAINE; GLUTAMIC ACID; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; FOOTSHOCK; MALE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; REINFORCEMENT; RELAPSE; STRESS; SYNAPSE;

AMINO ACIDS; ANALYSIS OF VARIANCE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; EXCITATORY AMINO ACID ANTAGONISTS; EXTINCTION, PSYCHOLOGICAL; MALE; PIPERIDINES; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; STRESS, PSYCHOLOGICAL; THIAZOLES;

EID: 84860243867     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2011.00345.x     Document Type: Article

References (46)

1. Anderson JJ, Bradbury MJ, Giracello DR, Chapman DF, Holtz G, Roppe J, King C, Cosford ND, Varney MA, (2003) In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2- ylethynyl)pyridine). Eur J Pharmacol 473: 35-40.
2. Aujla H, Martin-Fardon R, Weiss F, (2008) Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2/3 agonist LY379268 during abstinence. Neuropsychopharmacology 33: 1818-1826.
3. Backstrom P, Bachteler D, Koch S, Hyytia P, Spanagel R, (2004) mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology 29: 921-928.
4. Backstrom P, Hyytia P, (2005) Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG. Eur J Pharmacol 528: 110-118.
5. Baptista MA, Martin-Fardon R, Weiss F, (2004) Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer. J Neurosci 24: 4723-4727.
6. Belozertseva IV, Kos T, Popik P, Danysz W, Bespalov AY, (2007) Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. Eur Neuropsychopharmacol 17: 172-179.
7. Bossert JM, Busch RF, Gray SM, (2005) The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking. Neuroreport 16: 1013-1016.
8. Bossert JM, Gray SM, Lu L, Shaham Y, (2006) Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking. Neuropsychopharmacology 3: 2197-2209.
9. Busse CS, Brodkin J, Tattersall D, Anderson JJ, Warren N, Tehrani L, Bristow LJ, Varney MA, Cosford ND, (2004) The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl] pyridine (MTEP) in rodent models of anxiety. Neuropsychopharmacology 29: 1971-1979.
10. Caine SB, Lintz R, Koob GF, (1993) Intravenous drug self-administration techniques in animals. In:, Sahgal A, ed. Behavioral Neuroscience: A Practical Approach, Vol. 2, pp. 117-143. Oxford: Oxford University Press.
11. Cartmell J, Monn JA, Schoepp DD, (1999) The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther 291: 161-170.
12. Cartmell J, Monn JA, Schoepp DD, (2000a) Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine. Psychopharmacology (Berl) 148: 423-429.
13. Cartmell J, Perry KW, Salhoff CR, Monn JA, Schoepp DD, (2000b) The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat. J Neurochem 75: 1147-1154.
14. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S, Corsi M, Orzi F, Conquet F, (2001) Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4: 873-874.
15. Chojnacka-Wojcik E, Klodzinska A, Pilc A, (2001) Glutamate receptor ligands as anxiolytics. Curr Opin Investig Drugs 2: 1112-1119.
16. Cowen MS, Djouma E, Lawrence AJ, (2005) The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems. J Pharmacol Exp Ther 315: 590-600.
17. Ferraguti F, Shigemoto R, (2006) Metabotropic glutamate receptors. Cell Tissue Res 326: 483-504.
18. Hao Y, Martin-Fardon R, Weiss F, (2010) Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence. Biol Psychiatry 68: 240-248.
19. Imre G, (2007) The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268. CNS Drug Rev 13: 444-464.
20. Kalivas PW, O'Brien C, (2008) Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 33: 166-180.
21. van der Kam EL, de Vry J, Tzschentke TM, (2007) Effect of 2-methyl-6-(phenylethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat. Behav Pharmacol 18: 717-724.
22. Kenny PJ, Markou A, (2004) The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol Sci 25: 265-272.
23. Liechti ME, Lhuillier L, Kaupmann K, Markou A, (2007) Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence. J Neurosci 27: 9077-9085.
24. Martin-Fardon R, Baptista MA, Dayas CV, Weiss F, (2009) Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer. J Pharmacol Exp Ther 329: 1084-1090.
25. Martin-Fardon R, Ciccocioppo R, Massi M, Weiss F, (2000) Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. Neuroreport 11: 1939-1943.
26. Moussawi K, Kalivas PW, (2010) Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction. Eur J Pharmacol 639: 115-122.
27. Moussawi K, Pacchioni A, Moran M, Olive MF, Gass JT, Lavin A, Kalivas PW, (2009) N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci 12: 182-189.
28. O'Brien CP, Childress AR, Ehrman R, Robbins SJ, (1998) Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacol 12: 15-22.
29. Ohishi H, Shigemoto R, Nakanishi S, Mizuno N, (1993a) Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 53: 1009-1018.
30. Ohishi H, Shigemoto R, Nakanishi S, Mizuno N, (1993b) Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J Comp Neurol 335: 252-266.
31. Olive MF, (2009) Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Curr Drug Abuse Rev 2: 83-989.
32. Olive MF, McGeehan AJ, Kinder JR, McMahon T, Hodge CW, Janak PH, Messing RO, (2005) The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism. Mol Pharmacol 67: 349-355.
33. Palmatier MI, Liu X, Donny EC, Caggiula AR, Sved AF, (2008) Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine. Neuropsychopharmacology 33: 2139-2147.
34. Paterson NE, Markou A, (2005) The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacology (Berl) 179: 255-261.
35. Pinheiro PS, Mulle C, (2008) Presynaptic glutamate receptors: physiological functions and mechanisms of action. Nat Rev Neurosci 9: 423-436.
36. Schoepp DD, Cartmell J, Johnson BG, Salhoff CR, Wright RA, Tizzano JP, Monn JA, (2001) Metabotropic glutamate receptors: a novel approach to treat psychiatric disorders. In:, Turski L, Schoepp DD, Cavalheiro EA, eds. Excitatory Amino Acids: Ten Years Later, pp. 207-216. Washington, DC: IOS Press.
37. See RE, (2002) Neural substrates of conditioned-cued relapse to drug-seeking behavior. Pharmacol Biochem Behav 71: 517-529.
38. Sidhpura N, Weiss F, Martin-Fardon R, (2010) Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence. Biol Psychiatry 67: 804-811.
39. Sinha R, Fuse T, Aubin LR, O'Malley SS, (2000) Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl) 152: 140-148.
40. Spooren W, Ballard T, Gasparini F, Amalric M, Mutel V, Schreiber R, (2003) Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders. Behav Pharmacol 14: 257-277.
41. Spooren WP, Schoeffter P, Gasparini F, Kuhn R, Gentsch C, (2002) Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). Eur J Pharmacol 435: 161-170.
42. Spooren WP, Vassout A, Neijt HC, Kuhn R, Gasparini F, Roux S, Porsolt RD, Gentsch C, (2000) Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther 295: 1267-1275.
43. Swanson CJ, Bures M, Johnson MP, Linden AM, Monn JA, Schoepp DD, (2005) Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov 4: 131-144.
44. Varty GB, Grilli M, Forlani A, Fredduzzi S, Grzelak ME, Guthrie DH, Hodgson RA, Lu SX, Nicolussi E, Pond AJ, Parker EM, Hunter JC, Higgins GA, Reggiani A, Bertorelli R, (2005) The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Psychopharmacology (Berl) 179: 207-217.
45. Weiss F, (2005) Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol 5: 9-19.
46. Zhao Y, Dayas CV, Aujla H, Baptista MA, Martin-Fardon R, Weiss F, (2006) Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala. J Neurosci 26: 9967-9974.